Chromosomal instability in flat adenomas and carcinomas of the colon

Journal of Pathology

Volumn 205, Issue 4, 2005, Pages 514-521

  Postma, C ^a   Hermsen, M A J A ^a   Coffa, J ^a   Baak, J P A ^b   Mueller, J D ^c   Mueller, E ^c   Bethke, B ^d   Schouten, J P ^e   Stolte, M ^d   Meijer, G A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERGEN   (Norway)

^c BAYSTATE MEDICAL CENTER   (United States)

^d INSTITUTE OF PATHOLOGY   (Germany)

^e MRC HOLLAND   (Netherlands)

Author keywords

Chromosomal aberrations; Colon; Comparative genomic hybridization; Flat adenoma; Flat carcinoma; Multiplex ligation dependent probe amplification

Indexed keywords

DNA; PROTEIN BCL 2; TRANSCRIPTION FACTOR E2F1;

ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; COLON ADENOMA; COLON CARCINOMA; COLON POLYP; COLORECTAL TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; GENE AMPLIFICATION; GENE NUMBER; HUMAN; INDIVIDUALITY; KARYOTYPE; LARGE INTESTINE CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 20; COLONIC NEOPLASMS; DNA, NEOPLASM; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 20144366958     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1733     Document Type: Article

References (40)

1. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
2. Stolte M, Bethke B. Colorectal mini-de novo carcinoma: a reality in Germany too. Endoscopy 1995; 27: 286-290.
3. Muto T, Kamiya J, Sawada T, et al. Small 'flat adenoma' of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 1985; 28: 847-851.
4. Rubio CA, Kumagai J, Kanamori T, et al. Flat adenomas and flat adenocarcinomas of the colorectal mucosa in Japanese and Swedish patients. Comparative histologic study. Dis Colon Rectum 1995; 38: 1075-1079.
5. Wolber RA, Owen DA. Flat adenomas of the colon. Hum Pathol 1991; 22: 70-74.
6. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
7. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
8. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996; 15: 234-245.
9. Meijer GA, Hermsen MA, Baak JP, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998; 51: 901-909.
10. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002; 123: 1109-1119.
11. Weiss MM, Hermsen MA, Meijer GA, et al. Comparative genomic hybridisation. Mol Pathol 1999; 52: 243-251.
12. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
13. Chiang JM, Chou YH, Chou TB. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer. Cancer Res 1998; 58: 3289-3293.
14. Minamoto T, Sawaguchi K, Mai M, et al. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 1994; 54: 2841-2844.
15. Umetani N, Sasaki S, Masaki T, et al. Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis. Br J Cancer 2000; 82: 9-15.
16. Watanabe T, Muto T. Colorectal carcinogenesis based on molecular biology of early colorectal cancer, with special reference to nonpolypoid (superficial) lesions. World J Surg 2000; 24: 1091-1097.
17. Yamagata S, Muto T, Uchida Y, et al. Polypoid growth and K-ras codon 12 mutation in colorectal cancer. Cancer 1995; 75: 953-957.
18. Yashiro M, Carethers JM, Laghi L, et al. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 2001; 61: 2676-2683.
19. Leong AF, Seow-Choen F, Tang CL. Diminutive cancers of the colon and rectum: comparison between flat and polypoid cancers. Int J Colorectal Dis 1998; 13: 151-153.
20. Mueller JD, Haegle N, Keller G, et al. Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum. Am J Pathol 1998; 153 1977-1984.
21. Tada S, Yao T, Iida M, et al. A clinicopathologic study of small flat colorectal carcinoma. Cancer 1994; 74: 2430-2435.
22. Richter H, Slezak P, Walch A, et al. Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am J Pathol 2003; 163: 287-294.
23. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA-sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10: 231-243.
24. Takaku K, Oshima M, Miyoshi H, et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998; 92: 645-656.
25. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet 2000; 25: 144-146.
26. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003; 200: 320-326.
27. Collins C, Rommens JM, Kowbel D, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U SA 1998; 95: 8703-8708.
28. Collins C, Volik S, Kowbel D, et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001; 11: 1034-1042.
29. Nonet GH, Stampfer MR, Chin K, et al. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 2001; 61: 1250-1254.
30. Watanabe T, Imoto I, Katahira T, et al. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Jpn J Cancer Res 2002; 93: 1114-1122.
31. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000; 6: 1833-1839.
32. Ginzinger DG, Godfrey TE, Nigro J, et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000; 60: 5405-5409.
33. Hidaka S, Yasutake T, Takeshita H, et al. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-2717.
34. Larsen AK, Gobert C. DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde? Pathol Oncol Res 1999; 5: 171-178.
35. Zhao C, Yasui K, Lee CJ, et al. Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer 2003; 98: 18-23.
36. Tsujimoto Y, Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett 2000; 466: 6-10.
37. Krajewska M, Moss SF, Krajewski S, et al. Elevated expression of Bcl-X and reduced bak in primary colorectal adenocarcinomas. Cancer Res 1996; 56: 2422-2427.
38. Maurer CA, Friess H, Buhler SS, et al. Apoptosis inhibiting factor Bcl-x(L) might be the crucial member of the Bcl-2 gene family in colorectal cancer. Dig Dis Sci 1998; 43: 2641-2648.
39. Nevins Jr. The Rb/E2F pathway and cancer. Hum Mol Genet 2001; 10: 699-703.
40. Johnson DG, Cress WD, Jakoi L, Nevins Jr. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A 1994; 91: 12 823-12 827.